Home › Chronic Progressive Multiple Sclerosis
Pag-aaral pangklinika para sa Chronic Progressive Multiple Sclerosis na nagre-recruit sa U.S.
18 pag-aaral para sa Chronic Progressive Multiple Sclerosis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- St. Louis, MO4 pag-aaral
- Memphis, TN4 pag-aaral
- Chicago, IL4 pag-aaral
- Kansas City, KS3 pag-aaral
- Orlando, FL3 pag-aaral
- Tampa, FL3 pag-aaral
- Columbus, OH3 pag-aaral
- Greenville, SC3 pag-aaral
- Burbank, CA3 pag-aaral
Ayos sa estado
- Arizona3 pag-aaral
- California10 pag-aaral
- Florida3 pag-aaral
- Georgia3 pag-aaral
- Illinois5 pag-aaral
- Kansas4 pag-aaral
- Michigan4 pag-aaral
- Missouri4 pag-aaral
- North Carolina3 pag-aaral
- Ohio6 pag-aaral
- South Carolina3 pag-aaral
- Tennessee4 pag-aaral
- Texas4 pag-aaral
- Washington3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07840326A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07299019A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07067463Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Nagre-recruitPhase 1/2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07477639Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Nagre-recruitPhase 3
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04047628A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Nagre-recruitPhase 4
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07609719Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Nagre-recruitPhase 1/2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT03109288A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07225504Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Nagre-recruitPhase 1/2
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05359653Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
Nagre-recruitPhase 1
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT07139743Intermittent Hypoxia in Persons With Multiple Sclerosis
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT06276634A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT06138132Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Peb 23, 2026 · NCT06390930Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 12, 2026 · NCT07392879Home Based Functional Balance Intervention for Multiple Sclerosis
Nagre-recruit
Edad 40 hanggang 90 · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT07355387"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 31, 2025 · NCT07222618Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
Nagre-recruit
Edad 22 hanggang 75 · Lahat ng kasarian · Na-update Set 24, 2025 · NCT05964829MS-ResearchBiomarkerS
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryoMay bayad para sa mga kalahok
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 6, 2024 · NCT05204459Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.